AUROPHARMA - Bullish for Next One Month
Equity Traders : Buy 832 Target – 860 / 900 Stoploss – 800
Derivative Strategies: Buy Dec Fut at Rs.832 &Â Sell 860 Call at Rs.24 &Â Sell 800 Put at Rs.20
Profit Maximized at 860 Levels, This Strategy will outperform the future buying between 760 levels to 900 levels.Â
Performance Analysis
Aurobindo pharma has a very clear positive trend on daily basis, monthly basis and yearly basis. As per yesterday it is even outperformed market’s with strong positive sign rallying up over 1.81%
Making a higher close. closed higher than Thursday’s high .
NSE Ticker: AUROPHARMA
Company Name: Aurobindo pharma
Date of Analysis: 20 Nov 2015
Trend: Bullish CMP : 831
Even when markets could not hold at higher levels Aurobindo pharma sustained at high levels ,Which clearly over performed market .
The stock has not closed below 810 and has a huge support at the range of 800. The current market price is 832.
Derivative Segment Analysis
Retail Traders Have offloaded the significant long position on 19 Nov 2015
Retail Traders Have offloaded the significant long position on 19 Nov 2015
Auropharma November series future contract open interest have been reduced  significantly
Predominant raise in December series open interest of AuroPharma shows freash long positions created by FIIs
This can be derived by tracking Stock Derivative Activity of FII and Retails
Last 24 Months - TOP ACCUMULATED STOCK LIST
Auropharma is one of the top accumulated stock through bulk and Block Deals in Last 24 Months
The Vanguard Groups has purchased this stock significantly from the Market.
The Vanguard Groups has purchased some other stocks too from Indian markets, such as BOSCHLTD, EICHERMOTORS which are known for best picks.
excellent analysis.chanceless